Foley Awarded 2013 M&A Advisor Deal of the Year in Healthcare/Life Sciences Category
December 20, 2013
Foley is pleased to announce that the firm’s work with OxOnc Development LP, was awarded “Deal of the Year in the Healthcare/Life Sciences (between $10 million to $50 million)” category at the 12th annual M&A Advisor awards gala on December 17, 2013. Foley attorneys, along with investment bankers MTS Health Partners, assisted in the formation and financing of OxOnc Development LP and its simultaneous entry into a significant development relationship with Pfizer, Inc. for the clinical development in the Peoples’ Republic of China, Japan, Taiwan and South Korea of Pfizer’s product, Xalkori, for the treatment of certain varieties of lung cancer. The Foley team consisted of Selig Sacks, Rick Kaufman, Jamshed Patel, Michael Dana and Melisande Brodeur-Frohman.
The M&A Advisor Awards recognize the leading dealmakers, firms and transactions.
The M&A Advisor Awards recognize the leading dealmakers, firms and transactions.
People
Related News
November 18, 2025
Press Releases
Foley Announces Joe Dowdy as Raleigh Office Managing Partner
Foley & Lardner LLP has appointed litigator Joseph Dowdy as managing partner of the firm’s Raleigh, North Carolina, office.
October 20, 2025
Press Releases
Foley Welcomes 2025 New Associate Class
Foley & Lardner LLP welcomes its 2025 associate class—69 new lawyers and clerks across 18 offices and 16 practice areas—highlighting the firm’s nationwide commitment to top legal talent, professional development, and client service excellence.
October 15, 2025
Press Releases
Foley Expands National Litigation Capabilities with Addition of Two Partners in Washington, D.C.
Foley & Lardner LLP announced today that it has expanded its Litigation Department with the addition of Jason Levine and Teresa Taylor as partners in the firm’s Washington, D.C. office. Levine joins the firm’s Antitrust & Competition Practice Group, while Taylor joins the firm’s Government Enforcement Defense & Investigations (GEDI) Practice Group.